Precision Optics (NASDAQ:POCI) Posts Earnings Results

Precision Optics (NASDAQ:POCI) posted its quarterly earnings data on Wednesday. The company reported ($0.01) earnings per share for the quarter, FiscalAI reports. Precision Optics had a negative net margin of 28.33% and a negative return on equity of 60.56%. The company had revenue of $8.71 million for the quarter.

Here are the key takeaways from Precision Optics’ conference call:

• Precision Optics reported a record Q3 revenue of $8.7 million, more than doubling year over year, and achieved positive adjusted EBITDA of $300,000 for the first time in a key milestone quarter.
• The company’s largest production programs continued to drive results, led by the aerospace customer at $3.6 million in revenue and the single-use cystoscope at $2.2 million, both record highs.
• Operational improvements appear to be taking hold, with overall gross margin improving to 23.6% from 2.8% in the prior quarter and 10% a year ago, helped by higher yields, throughput, and cost discipline.
• Management raised fiscal 2026 revenue guidance to $29 million-$31 million and tightened adjusted EBITDA guidance to negative $2.5 million to negative $2.7 million, reflecting improved visibility but still expecting a full-year loss.
• The balance sheet was strengthened by an oversubscribed $10 million public offering, leaving cash at $10.7 million and giving the company more flexibility to support growth and manufacturing investments.

Precision Optics Price Performance

Shares of Precision Optics stock opened at $4.60 on Thursday. The company has a current ratio of 1.05, a quick ratio of 0.62 and a debt-to-equity ratio of 0.11. Precision Optics has a 12 month low of $3.55 and a 12 month high of $6.04. The stock has a 50 day moving average of $4.32 and a 200 day moving average of $4.44. The firm has a market cap of $35.56 million, a PE ratio of -5.00 and a beta of 0.23.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Precision Optics in a report on Thursday, January 22nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Institutional Investors Weigh In On Precision Optics

Large investors have recently bought and sold shares of the business. Jane Street Group LLC bought a new position in Precision Optics during the fourth quarter valued at $48,000. Citadel Advisors LLC bought a new stake in shares of Precision Optics in the 3rd quarter worth about $49,000. DRW Securities LLC purchased a new stake in shares of Precision Optics during the 4th quarter valued at about $94,000. Geode Capital Management LLC lifted its holdings in shares of Precision Optics by 3.4% in the 4th quarter. Geode Capital Management LLC now owns 58,436 shares of the company’s stock valued at $245,000 after acquiring an additional 1,926 shares during the last quarter. Finally, WealthTrust Axiom LLC lifted its holdings in shares of Precision Optics by 2.7% in the 4th quarter. WealthTrust Axiom LLC now owns 231,808 shares of the company’s stock valued at $970,000 after acquiring an additional 6,158 shares during the last quarter. Institutional investors own 13.71% of the company’s stock.

Precision Optics Company Profile

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.